Drawing for CYROLITE

USPTO serial 97519740

CYROLITE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
GILBERT, REBECCA L
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CYROLITE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Scott D. Woldow

Scott D. Woldow SMITH, GAMBRELL & RUSSELL, LLP1055 THOMAS JEFFERSON ST, NW, SUITE 400WASHINGTON, DC 20007United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, namely, Antibacterial pharmaceuticals; Antidiabetic pharmaceuticals; Cardiovascular pharmaceuticals; Dermatological pharmaceuticals; Inhaled pharmaceuticals for the treatment of respiratory diseases and disorders; Injectable pharmaceuticals for the treatment of respiratory diseases and disorders; Ocular pharmaceuticals; Pharmaceutical antidepressants; Pharmaceutical anticoagulants; Pharmaceutical appetite suppressants; Pharmaceuticals for the treatment of infectious diseases; Pharmaceuticals for wounds; Pharmaceutical skin lotions; Anti-infective pharmaceuticals; veterinary preparations, namely, veterinary vaccines; veterinary preparations used in livestock breeding, namely, hormones and amino acids; veterinary preparations, namely, pain relief medication; medical and veterinary preparations and articles, namely, Bandages for dressings, bandages for skin wounds and surgical dressings; Dressings for burns; Dressings for wounds, Dressings for surgery; Self adhesive dressings; adjuvants for medical purposes; drug delivery agents in the form of a coating for tablets that facilitate the delivery of a wide range of pharmaceuticals; dental lacquers; glazes for pharmaceutical veterinary and dietetic preparations, namely, glazes for tablets to facilitate the delivery of pharmaceuticals; chemical preparations for medical, pharmaceutical or veterinary purposes, namely, to facilitate the delivery of pharmaceuticals; cellulose esters for pharmaceutical purposes; diagnostic preparations for medical purposes; medicated chewing gum; gamboge for medical purposes, namely, to facilitate the delivery of pharmaceuticals; chemico-pharmaceutical preparations, namely, Medical diagnostic reagents for the analysis of body fluids; surgical implants comprising living tissue; capsules sold empty for pharmaceuticals; sanitary preparations for medical use; dietetic foods and dietetic preparations, namely, pasta, crackers, and sugar adapted for medical or veterinary use; dietary supplements; food for babies; plasters for medical purposes; materials for dressings, namely, gauze and wadding for dressings; material for stopping teeth, dental wax; disinfectants for sanitary purposes; preparations for destroying vermin; fungicides, herbicidesACTIVE—
010Surgical apparatus and instruments for medical, dental or veterinary use all of the aforementioned goods not for use in the field of cryotherapy; Surgical and medical apparatus and instruments for use in general surgery all of the aforementioned goods not for use in the field of cryotherapy; probes for medical purposes; medical devices for protecting patients against X-ray exposure; drainage tubes for medical purposes; enteral feeding pumps and valves for medical purposes; medical containers and packaging therefor especially made for medical waste; feeding bottles; elastic bandages; artificial limbs and implants consisting of artificial materials; stents; syringes for medical purposes; catheters; cannulae; acupuncture needles; suture needles; artificial limbs, eyes and teeth; medical guide wires; orthopedic articles, namely, orthopedic supports; suture materials; parts and fittings for all of the aforesaid goodsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 7, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 7, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 6, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 5, 2024EX1GSOU EXTENSION 1 GRANTED—
Mar 5, 2024EXT1SOU EXTENSION 1 FILED—
Mar 5, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 5, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 11, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 11, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 21, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 2, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 1, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 31, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 31, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 18, 2023XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Apr 18, 2023XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Jan 18, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 18, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 18, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 18, 2023DOCKASSIGNED TO EXAMINER—
Aug 17, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 29, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance